Morgan Stanley Maintains Overweight on Equifax, Lowers Price Target to $205
Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:EFX) with a Overweight and lowers the price target from $225 to $205.
Share
Why It Matters
A big bank analyst still likes Equifax but thinks it might be worth less money soon. When experts lower their price goals, it means they see some bumps ahead for the company.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.